What PRN is trying to do
Peptide Research News uses automation to monitor a fast-moving topic, but the useful product is the organization around that feed: evidence levels, source hierarchy, regulatory context, supplier transparency and clear research-use-only boundaries.
Essential peptide guides
BPC-157
One of the most searched research peptides, but still dominated by preclinical and limited human evidence.
Read guide →TB-500
A useful example of the gap between online recovery claims and the human evidence base.
Read guide →Semaglutide
A peptide-related drug class with unusually strong clinical evidence and mainstream prescription use.
Read guide →Tirzepatide
A high-interest metabolic therapy with large clinical trial programs and growing access questions.
Read guide →Trust and monetization foundations
Start Here
The easiest reader path through PRN: guides, research, Canada resources, supplier standards and newsletter updates.
Open resource →Most important peptide studies of 2026
A living editorial watchlist for the peptide research themes PRN is tracking most closely.
Open resource →BPC-157 studies that actually matter
A focused guide that separates BPC-157 research signals from recovery-culture hype.
Open resource →Peptide COA red flags
A practical supplier due-diligence checklist readers can use before clicking commercial links.
Open resource →How to read a peptide COA
A practical testing guide for HPLC, mass spectrometry, batch identity and supplier transparency.
Open resource →Research supplier standards
How PRN evaluates research-use suppliers without pretending affiliate links are editorial proof.
Open resource →Purity Peptides review
A deeper look at the current PRN partner using testing, transparency and compliance criteria.
Open resource →Editorial policy
How PRN uses source hierarchy, automation, human editing, affiliate disclosures and corrections.
Open resource →